FWWMX
Price
$66.28
Change
+$0.23 (+0.35%)
Updated
Nov 19 closing price
Net Assets
203.68B
JHJIX
Price
$24.46
Change
+$0.08 (+0.33%)
Updated
Nov 19 closing price
Net Assets
117.84M
Interact to see
Advertisement

FWWMX vs JHJIX

Header iconFWWMX vs JHJIX Comparison
Open Charts FWWMX vs JHJIXBanner chart's image
American Funds Washington Mutual 529-F-3
Price$66.28
Change+$0.23 (+0.35%)
VolumeN/A
Net Assets203.68B
JHancock ESG Large Cap Core I
Price$24.46
Change+$0.08 (+0.33%)
VolumeN/A
Net Assets117.84M
FWWMX vs JHJIX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FWWMX has more cash in the bank: 204B vs. JHJIX (118M). FWWMX pays higher dividends than JHJIX: FWWMX (1.41) vs JHJIX (0.26). FWWMX was incepted earlier than JHJIX: FWWMX (5 years) vs JHJIX (9 years). JHJIX (1.08) is less costly to investors than FWWMX (0.31). JHJIX (30.00) and FWWMX (29.00) have comparable annual turnover. FWWMX has a lower initial minimum investment than JHJIX: FWWMX (250) vs JHJIX (250000). FWWMX annual gain was more profitable for investors over the last year : 4.60 vs. JHJIX (-4.23). FWWMX return over 5 years is better than : 49.02 vs. JHJIX (45.15).
FWWMXJHJIXFWWMX / JHJIX
Total Expense Ratio0.310.8736%
Annual Report Gross Expense Ratio0.311.0829%
Fund Existence5 years9 years-
Gain YTD8.9177.212124%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets204B118M172,881%
Annual Yield % from dividends1.410.26535%
Returns for 1 year4.60-4.23-109%
Returns for 3 years30.9834.5590%
Returns for 5 years49.0245.15109%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTCAX20.510.08
+0.39%
BNY Mellon Sust US Equity A
MSVMX6.15N/A
N/A
Morgan Stanley Vitality Portfolio C
UOPSX93.08N/A
N/A
ProFunds UltraNASDAQ-100 Svc
VSFSX24.70-0.05
-0.20%
Federated Hermes Clover Small Value R6
JFNCX68.22-0.15
-0.22%
Janus Henderson Global Life Sciences C